As our company continues to evolve, we’re excited to announce that effective June 1st, 2026, Sapreme Development B.V. will become Sapreme Therapeutics B.V.
Over the past years, our focus has progressed from platform technology toward the development of a growing portfolio of therapeutic programs.
Our new name reflects that evolution and our future as a therapeutics-focused biotech company.
This is a name change only, and we look forward to continuing this journey together with our partners, collaborators, and broader network.